Bioadaptives, Inc.
BDPT OTC
SEC CIK 1575142
Follow Bioadaptives
Weekly email: filings, results, news
Revenue, last quarter
$5K
+55% vs same quarter last year
Net income
$150.1K
+195% vs same quarter last year
EPS, diluted
$0.00
+100% vs same quarter last year
Operating cash flow
−$44.4K
+60% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $18.3K | −$1.6M |
| FY24 | $12.7K | −$899.2K |
| FY23 | $28.6K | −$712.5K |
| FY22 | $17.2K | −$895.6K |
| FY21 | $19.8K | −$1M |
| FY20 | $16.3K | −$847.2K |
| FY19 | $9.9K | −$238.9K |
| FY18 | - | −$1.4M |
| FY17 | - | - |
| FY15 | - | −$227.4K |
| FY14 | - | −$2.6M |
| FY13 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 68.4% | −5701.8% | −8523.4% |
| FY24 | 31.8% | −4752.5% | −7097.3% |
| FY23 | 37.9% | −801.4% | −2494.2% |
| FY22 | 41.5% | −2456.3% | −5214.1% |
| FY21 | 51.1% | - | −5309.2% |
| FY20 | 37.3% | - | −5189.2% |
| FY19 | 49.2% | - | −2405.1% |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$534K |
| FY24 | −$249.5K |
| FY23 | - |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY15 | - |
| FY14 | −$60.2K |
| FY13 | - |
- Bioadaptives
- Healthcare median
Show the numbers
| Year | Bioadaptives | Healthcare median |
|---|---|---|
| FY25 | −8523.4% | −40.6% |
| FY24 | −7097.3% | −60.7% |
| FY23 | −2494.2% | −97.1% |
| FY22 | −5214.1% | −128.5% |
| FY21 | −5309.2% | −129.2% |
| FY20 | −5189.2% | −136.5% |
| FY19 | −2405.1% | −133.7% |
| FY18 | - | −173.4% |
| FY17 | - | −176.7% |
| FY15 | - | −183.4% |
| FY14 | - | −133% |
| FY13 | - | −88.5% |
News
No stories filed under Bioadaptives yet - coverage appears here as the news feed clusters it.